Pulmonary hypertension (PH) is a severe complication of sarcoidosis, with an unknown
prevalence. The aetiology is multifactorial, and the exact mechanism of PH in the individual …

Pulmonary hypertension (PH) is a well-known complication of sarcoidosis, defined by a
mean pulmonary artery pressure of ≥25 mm Hg. Since both PH and sarcoidosis are rare …

Sarcoidosis is a systemic disease of an unknown aetiology, in which noncaseating
granulomas are formed in one or multiple organs, with pulmonary involvement in >90% of the …

Pulmonary hypertension (PH) is a known complication of pulmonary sarcoidosis with a
prevalence ranging from 5% to 74% [1]. The aetiology of PH in sarcoidosis is not fully understood…

Background: Pulmonary hypertension (PH) is a known complication of pulmonary sarcoidosis
and is associated with higher morbidity and mortality. Currently, there are no approved PH-…

Conclusions: In this real world multicenter cohort of sarcoidosis patients, we found a significant
correlation between RVSP as determined by echocardiography and invasive PASP. Over-…

Aims Pulmonary hypertension (PH) is associated with mortality after transcatheter aortic valve
implantation (TAVI). However, diagnosis based on tricuspid regurgitant velocity (TRV) is …

Pulmonary hypertension (PH) is a well-recognised complication of sarcoidosis. Non-invasive
diagnosis is challenging due to limited accuracy of echocardiography in interstitial lung …

Background: Pulmonary hypertension (PH) is a severe complication of sarcoidosis in a
minority of patients. Several genetic defects are known to cause hereditary or sporadic PH, but …

Background and objective Pulmonary hypertension (PH) is a known complication of pulmonary
sarcoidosis and its aetiology is unclear. Different pathophysiological mechanisms in …